Literature DB >> 20961758

Fukutin mutations in non-Japanese patients with congenital muscular dystrophy: less severe mutations predominate in patients with a non-Walker-Warburg phenotype.

Uluc Yis1, Gökhan Uyanik, Pinar Bambul Heck, Martin Smitka, Hannes Nobel, Friedrich Ebinger, Eray Dirik, Lucy Feng, Semra H Kurul, Katja Brocke, Aycan Unalp, Erdener Özer, Handan Cakmakci, Caroline Sewry, Sebahattin Cirak, Francesco Muntoni, Ute Hehr, Deborah J Morris-Rosendahl.   

Abstract

Six genes including POMT1, POMT2, POMGNT1, FKRP, Fukutin (FKTN) and LARGE encode proteins involved in the glycosylation of α-dystroglycan (α-DG). Abnormal glycosylation of α-DG is a common finding in Walker-Warburg syndrome (WWS), muscle-eye-brain disease (MEB), Fukuyama congenital muscular dystrophy (FCMD), congenital muscular dystrophy types 1C and 1D and some forms of autosomal recessive limb-girdle muscular dystrophy (LGMD2I, LGMD2K, LGMD2M), and is associated with mutations in the above genes. FCMD, caused by mutations in Fukutin (FKTN), is most frequent in Japan, but an increasing number of FKTN mutations are being reported outside of Japan. We describe four new patients with FKTN mutations and phenotypes ranging from: severe WWS in a Greek-Croatian patient, to congenital muscular dystrophy and cobblestone lissencephaly resembling MEB-FCMD in two Turkish patients, and limb-girdle muscular dystrophy and no mental retardation in a German patient. Four of the five different FKTN mutations have not been previously described.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20961758     DOI: 10.1016/j.nmd.2010.08.007

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  9 in total

Review 1.  The o-mannosylation pathway: glycosyltransferases and proteins implicated in congenital muscular dystrophy.

Authors:  Lance Wells
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

2.  Ataxia, intellectual disability, and ocular apraxia with cerebellar cysts: a new disease?

Authors:  Andrea Poretti; Martin Häusler; Arpad von Moers; Bastian Baumgartner; Klaus Zerres; Andrea Klein; Chiara Aiello; Francesca Moro; Ginevra Zanni; Filippo M Santorelli; Thierry A G M Huisman; Joachim Weis; Enza Maria Valente; Enrico Bertini; Eugen Boltshauser
Journal:  Cerebellum       Date:  2014-02       Impact factor: 3.847

Review 3.  The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy.

Authors:  Jamie L Marshall; Yukwah Kwok; Brian J McMorran; Linda G Baum; Rachelle H Crosbie-Watson
Journal:  FEBS J       Date:  2013-05-13       Impact factor: 5.542

Review 4.  O-Mannosylation and human disease.

Authors:  Christina M Dobson; Samuel J Hempel; Stephanie H Stalnaker; Ryan Stuart; Lance Wells
Journal:  Cell Mol Life Sci       Date:  2012-11-01       Impact factor: 9.261

5.  Novel mutation in the fukutin gene in an Egyptian family with Fukuyama congenital muscular dystrophy and microcephaly.

Authors:  Samira Ismail; Ashleigh E Schaffer; Rasim O Rosti; Joseph G Gleeson; Maha S Zaki
Journal:  Gene       Date:  2014-02-13       Impact factor: 3.688

Review 6.  A developmental and genetic classification for malformations of cortical development: update 2012.

Authors:  A James Barkovich; Renzo Guerrini; Ruben I Kuzniecky; Graeme D Jackson; William B Dobyns
Journal:  Brain       Date:  2012-03-16       Impact factor: 13.501

7.  Congenital protein hypoglycosylation diseases.

Authors:  Susan E Sparks
Journal:  Appl Clin Genet       Date:  2012-07-05

8.  Global genetic determinants of mitochondrial DNA copy number.

Authors:  Hengshan Zhang; Keshav K Singh
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

9.  Illness-associated muscle weakness in dystroglycanopathies.

Authors:  Courtney R Carlson; Steven D McGaughey; Jamie M Eskuri; Carrie M Stephan; M Bridget Zimmerman; Katherine D Mathews
Journal:  Neurology       Date:  2017-11-03       Impact factor: 9.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.